Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
June 9, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-164639.pdf 0001193125-20-164639.rtf 0001193125-20-164639.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
June 9, 2020	4	Statement of changes in beneficial ownership of securities	0001562180-20-004356.pdf 0001562180-20-004356.rtf 0001562180-20-004356.xls View HTML
June 9, 2020	4	Statement of changes in beneficial ownership of securities	0001562180-20-004355.pdf 0001562180-20-004355.rtf 0001562180-20-004355.xls View HTML
June 9, 2020	4	Statement of changes in beneficial ownership of securities	0001562180-20-004354.pdf 0001562180-20-004354.rtf 0001562180-20-004354.xls View HTML
June 9, 2020	4	Statement of changes in beneficial ownership of securities	0001562180-20-004357.pdf 0001562180-20-004357.rtf 0001562180-20-004357.xls View HTML
June 9, 2020	4	Statement of changes in beneficial ownership of securities	0001562180-20-004358.pdf 0001562180-20-004358.rtf 0001562180-20-004358.xls View HTML
June 9, 2020	4	Statement of changes in beneficial ownership of securities	0001562180-20-004360.pdf 0001562180-20-004360.rtf 0001562180-20-004360.xls View HTML
June 9, 2020	4	Statement of changes in beneficial ownership of securities	0001562180-20-004359.pdf 0001562180-20-004359.rtf 0001562180-20-004359.xls View HTML
June 2, 2020	4	Statement of changes in beneficial ownership of securities	0001562180-20-004068.pdf 0001562180-20-004068.rtf 0001562180-20-004068.xls View HTML
May 21, 2020	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-20-148687.pdf 0001193125-20-148687.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax